ASPMN®’s Director of Government Affairs keeps us informed of bills and policies that matter most. A Washington presence ensures that pain management issues are heard and represented when bills and regulations are proposed or amendments to them are suggested. We use our governmental affairs program to educate Congress, and the Administration on all of our issues. Additionally, we further use it to ensure that we are also represented in issues of importance to our field that arise in the states.
ASPMN® Government Affairs Director
Organizational Advocacy Statements
This year ASPMN®’s Communications Committee began work on a series of organizational advocacy statements around current issues of importance to pain management. Internally we all know that ASPMN®’s members have a wealth of knowledge in the field of pain management, but we need to make sure everyone knows it. These papers are intended to give elected officials, media, and other interested parties a snapshot of our expertise on topics of national interest, and to invite them to engage us in more in-depth conversations.
Statement on the Use of Medical Marijuana
Multimodal Therapies to Manage Pain – More than Just Opioids
Statement on Abuse Deterrent Formulations
Statement on Nurses’ Use of Integrative Therapies for Pain
Statement Regarding the Use of Opioids for Chronic Pain While Preventing Abuse and Diversion
In Defense of Education
NIH HEAL Initiative
The document can be found
WHO Guidelines - ASPMN® Comment May 12, 2021
The document can be found
The Pain Management Best Practices Inter-Agency Task Force Report Final Report was released in the spring of 2019.
The final report can be found
ASPMN® on Capitol Hill, September 2018
Presenting to the Nursing Community
Senator Brown’s (D-OH) Office
Senate staff and American Organization of Nurse Executives Staff
House Nursing Caucus Vice Chair
Rodney Davis (R-IL)
House Nursing Caucus Vice Chair
Suzanne Bonamici (D-OR)
House Nursing Caucus Co-Chair David Joyce (R-OH)
The President's Commission on Combating Drug Addiction and the Opioid Crisis released their final report on Wednesday, November 1, 2017.
Report can be found here
Advance Copy of Opioid Declaration Fact Sheet Available
The link below is an advanced copy of the fact sheet for the President's announcement regarding the opioid crisis.
Fact Sheet Opioid Declaration 10-26-2017
ASPMN® Letter To Dr. Scott Gottlieb, MD, Commissioner, Food and Drug Administration
Click here to view letter
Commission on Combating Drug Addiction and the Opioid Crisis Interim Report
The President's Commission on Combating Drug Addiction and the Opioid Crisis has released a draft interim report that they will be delivering to President Trump. This Commission was established by President Trump in March, and is chaired by Governor Chris Christie. The charge of the Commission is to study ways to combat and treat drug abuse, addiction, and the opioid crisis.
Click here to view
The Office of the Assistant Secretary for Health at the U.S. Department of Health and Human Services today released a National Pain Strategy, outlining the federal government's first coordinated plan for reducing the burden of chronic pain that affects millions of Americans. The National Pain Strategy is a roadmap toward achieving a system of care in which all people receive appropriate, high quality and evidence-based care for pain.
Please share within your networks as appropriate.
National Pain Strategy
National Pain Strategy Press Release
ASPMN® responds to statements by Senator Angus King (D-MA) and Hillary Clinton on pain medications for children.
Click on links below to view:
Response to Senator King
Response to Hillary Clinton
CDC Draft Opioid Prescribing Guidelines
The Center for Disease Control (CDC) held a webinar on Wednesday, September 16, on Opioid Prescribing Guidelines. During this webinar they released draft recommendations. The following are the slides that include those recommendations.
CDC Draft Opioid Rx Guidelines Webinar Slides
The CDC announced they were accepting comments during this presentation and we provided them. They also announced that the deadline for additional comments was Friday, September 18. ASPMN® submitted additional comments as well which are
Update February 17, 2016
The CDC opened an additional public comment period that closed in early January. ASPMN®’s comments are
CDC Draft Opioid Rx Guidelines
Current CDC Guideline for Prescribing Opioids for Chronic Pain
Recap of PAINS Collaborators Meeting
by Myra Christopher, PAINS Director
In anticipation of publication of the National Pain Strategy (NPS) Report, in June, 2015 the Pain Action Alliance to Implement a National Strategy (PAINS), a coalition of national leaders and organizations committed to advancing the sixteen recommendations made in the Institutes of Medicine’s report, Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research, convened a Collaborators Conference in Washington, DC. The purpose of the meeting was to discern opportunities and challenges to implementation of the report, to build enthusiasm for it and promote collaboration among attendees in order to move the NPS Report from a vision to a reality. More than 100 prominent leaders from professional societies, academic institutions, federal agencies, patient advocacy groups, and policy organizations met to review the NPS Report and discuss each of its six sections.
Read the Full Executive Summary
The Nursing Community, a coalition of over 60 nursing organization which ASPMN® is a part of, held a series of events and meetings in Washington, DC on September 8th & 9th to celebrate the 50th Anniversary of Title VIII Nursing Workforce Development Programs. ASPMN® President Pat Bruckenthal is pictured with Congresswoman Lois Capps (D-CA) a nurse, and Congressman David Joyce (R-OH) married to a nurse, at a Capitol Hill Reception. The two Members of Congress are on the Congressional Nursing Caucus, and addressed the attendees during the reception.
Role of the Pain Management Nurse
ASPMN® as a Member of The Alliance for Balanced Pain Management recently released the following advertisement in
Click here to view the ad.
ASPMN® Sends Letter to Health Canada Regarding Abuse Deterrent Drugs
Click here for the letter
ASPMN®'s Statement Regarding the Misuse and Abuse of Opioids
Click here for the statement
ASPMN®Legislative Toolkit now available! If you have suggestions to include in the toolkit, please contact
RELIEVING PAIN IN AMERICA" -Institute of Medicine Report Highlights For the full report, contact
Wade Delk, ASPMN® Government Affairs Director.
ASPMN® Statement of Support
A Call to Revolutionize Pain
Care in America